In the latest trading session, Viatris (VTRS) closed at $14.07, marking a -1.57% move from the previous day. This change lagged the S&P 500's 0.54% loss on the day.

Prior to today's trading, shares of the generic drugmaker had lost 3.12% over the past month. This has was narrower than the Medical sector's loss of 3.77% and lagged the S&P 500's gain of 3.05% in that time.

VTRS will be looking to display strength as it nears its next earnings release, which is expected to be August 9, 2021. On that day, VTRS is projected to report earnings of $0.88 per share, which would represent a year-over-year decline of 20.72%. Our most recent consensus estimate is calling for quarterly revenue of $4.37 billion, up 60.1% from the year-ago period.

It is also important to note the recent changes to analyst estimates for VTRS. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.

The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.19% higher within the past month. VTRS is holding a Zacks Rank of #4 (Sell) right now.

Investors should also note VTRS's current valuation metrics, including its Forward P/E ratio of 3.99. This valuation marks a discount compared to its industry's average Forward P/E of 33.18.

The Medical Services industry is part of the Medical sector. This group has a Zacks Industry Rank of 114, putting it in the top 45% of all 250+ industries.

The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Make sure to utilize Zacks. Com to follow all of these stock-moving metrics, and more, in the coming trading sessions.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Viatris Inc. (VTRS) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.